Aedifica

Aedifica reports an EPRA result per share of €2.71 (+5%) for H1 2026 and a 62% rise in rental income following the merger with Cofinimmo. Management confirms run‑rate synergies of at least €16 million by 2027 (€5–5.5 million for 2026) and an average occupancy of the care‑home portfolio of 91%. The group maintains its full‑year guidance for EPRA result per share at €5.35 but shows a gearing ratio of 42.7% and a refinancing need of around €2.2 billion for 2027–2028. » Más en de.investing.com

Aedifica reports rental growth of 6.8% in fiscal 2025 to €361m and an EPRA result of €244.8m (+4.3%). Adjusted earnings per share rose to €5.15, beating the company’s guidance and market consensus; an EPRA earnings per share of €5.20 is expected for 2026. The operating margin and occupancy rates improved, portfolio value stands at €6.3bn, and the EPRA LTV ratio fell to 39.7%. Aedifica announces a dividend of €4.00 per share, up 2.6% year on year. » Más en de.investing.com

Belgian competition authority has approved Aedifica’s acquisition of Cofinimmo but requires the sale of healthcare properties in Belgium worth €300m over several years. With the clearance, the acceptance period begins on 30 January and runs until 2 March; results will be announced on 6 March and the first payment is scheduled for 13 March. The merger would create the largest listed healthcare real estate REIT in Europe with a portfolio of over €12bn. » Más en de.investing.com